FDMT4D Molecular Therapeutics, Inc.
$10.78+2.5% 1Y
$10.78
$7.1952 weeks$16.74
Is the price fair?
What FDMT's price assumes
- Price / book
- 2.29
Price / book · as of 2026-Q2
Details›
- Price / bookas of 2026-Q2
- 2.29
- EV / EBIToperating margin −214%: the multiple describes the denominator
- not meaningful
- Market capitalisation55.2 million shares, counted Aug 10, 2026
- $596M
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.